ArticleMikrochimica acta2026
Disposable screen-printed electrodes modified with oxygen-terminated moalb-derived mbene for low-potential detection of vortioxetine.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Vortioxetine (VOX) is a multimodal antidepressant commonly used in long-term therapy, making its sensitive detection in biological samples an important analytical task. Electrochemical detection of VOX on disposable carbon electrodes is often hindered by oxidation at relatively positive potentials, which can lead to background currents, co-oxidation, and surface passivation, thereby reducing analytical reliability. Herein, a fluoride-free alkaline hydrothermal route was adopted to convert MoAlB (MAB) into porous, oxygen-terminated MoAl
Indexed as
Identifiers
42458131What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.